Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison.

Suzanne V ArnoldJonathan YapCarolyn S P LamFengming TangWan T TayTiew H K TengDarren K McGuireJames L JanuzziGregg C FonarowFrederick A MasoudiMikhail Naum Kosiborod

Published in: Diabetes, obesity & metabolism (2018)

In both the United States and Asia, opportunities for improvement in the use of evidence-based therapies exist for patients with both diabetes and HFrEF. Effective tools to guide medication choices for these complex, high-risk patients could have substantial impact on quality and outcomes.

Keyphrases

heart failure
end stage renal disease
type diabetes
ejection fraction
chronic kidney disease
cardiovascular disease
peritoneal dialysis
prognostic factors
emergency department
metabolic syndrome
patient reported